Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
 		Keyword(s):
Year:  Vol:  Page: 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Whitmer, R. A.
Right arrow Articles by Yaffe, K.
Right arrow Articles citing this Article
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitmer, R. A.
Right arrow Articles by Yaffe, K.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 58:M324-M330 (2003)
© 2003 The Gerontological Society of America

Hormone Replacement Therapy and Cognitive Performance: The Role of Homocysteine

Rachel A. Whitmer1, Mary N. Haan2, Joshua W. Miller3 and Kristine Yaffe4

1 School of Public Health, University of California at Berkeley, and Kaiser Permanente Medical Care Program, Oakland, California.
2 Department of Epidemiology, University of Michigan, Ann Arbor.
3 Department of Medical Pathology, University of California at Davis.
4 Department of Psychiatry, Neurology, and Epidemiology, University of California at San Francisco.

Background. Clinical trials have shown that estrogen reduces levels of homocysteine, and recent work has shown that elevated homocysteine increases the risk of incident dementia. However, no studies have investigated whether reduction of homocysteine is a mechanism by which estrogen enhances cognitive functioning. The aim of this study was to examine whether the association between homocysteine and cognitive functioning varies by use of hormone replacement therapy (HRT) in postmenopausal women.

Methods. Serum values of homocysteine, HRT status, and two measures of cognitive functioning, the Modified Mini-Mental State Exam (3MSE) and the Delayed Word Recall Test (DELREC), were measured in 1041 elderly women of Latino background. Multiple linear regression models were done to examine whether HRT could modify the effect of homocysteine on cognitive functioning.

Results. All findings were adjusted for age, education, income, acculturation, and hysterectomy status. Those subjects on HRT (21%) had 3MSE scores 1.88 points higher (p <.001), DELREC scores 0.12 points higher (p =.06), and homocysteine levels 1.19 µmol/L lower (p <.001) than those not on HRT. Among those not on HRT, the 3MSE was 11.8 points lower and DELREC 1.98 points lower for every 10 µmol/L increase in homocysteine. Among those on HRT, homocysteine was not associated with cognitive functioning. This interaction was not attenuated by further adjustment for lipids, blood pressure, creatinine, folate, Vitamin B12, and cardiovascular disease (p <.001, interaction term coefficient for 3MSE and for DELREC).

Conclusions. Women taking HRT may modify the effects of homocysteine levels on cognitive functioning. Further work in randomized clinical trials is needed to examine whether reducing homocysteine levels with HRT can prevent cognitive decline or incident dementia.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2003 by The Gerontological Society of America.